Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 290

Results For "IMI"

3581 News Found

Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals
interviews | March 10, 2022

Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals

As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma


Gujarat Biotech policy offers incentives to attract small and large firms
News | March 10, 2022

Gujarat Biotech policy offers incentives to attract small and large firms

The Gujarat Biotechnology policy released last month has made radical changes to position the state as a biotechnology hub. It already has a thriving ecosystem of pharma companies and varied suppliers


Lupin Diagnostics opens first Reference Lab in East India
Diagnostic Center | March 10, 2022

Lupin Diagnostics opens first Reference Lab in East India

It is also setting up laboratories in West Bengal, Assam, Bihar, Jharkhand and Orissa to comprehensively cater to the East India region


Molecular Health and researchers prove new approach to anticipate molecular causation
Biotech | March 10, 2022

Molecular Health and researchers prove new approach to anticipate molecular causation

The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts


USFDA approves Evoke Spinal Cord Stimulation System
Drug Approval | March 09, 2022

USFDA approves Evoke Spinal Cord Stimulation System

Transformative closed-loop technology senses the spinal cord's response to stimulation and instantaneously adjusts therapy to sustain durable, optimized treatment


OpenEye Scientific and Gaussian collaboration expands quantum chemistry calculations
Biotech | March 09, 2022

OpenEye Scientific and Gaussian collaboration expands quantum chemistry calculations

Using Orion, pharmaceutical and biotechnology companies, as well as any industrial researcher who wishes to perform electronic structure calculations, can gain access to elastic and flexible computational resources in the Cloud


Lonza completes expansion of API manufacturing Lab in Nansha, China
News | March 08, 2022

Lonza completes expansion of API manufacturing Lab in Nansha, China

The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers


Industry upbeat on biopharma sector
News | March 08, 2022

Industry upbeat on biopharma sector

Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector


LifeCell India initiative to identify breast cancer risk in women
Healthcare | March 08, 2022

LifeCell India initiative to identify breast cancer risk in women

The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age


GOQii survey points to rise in women medical issues
Public Health | March 08, 2022

GOQii survey points to rise in women medical issues

Women's health is in fact a direct reflection of the nation's overall health